Prothena | PRTA - Interest Income

Stock Price
9.76
Daily Change
-0.10 -1.01%
Monthly
-7.22%
Yearly
35.93%
Q2 Forecast
9.47

Prothena reported $3.35M in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
Acadia Pharmaceuticals USD 8.33M 86K Dec/2025
Agios Pharmaceuticals USD 12.41M 959K Dec/2025
ALKERMES USD 8.54M 3.59M Mar/2026
Alnylam Pharmaceuticals USD 26.63M 2.05M Dec/2025
Biogen USD 37.9M 700K Mar/2026
BioMarin Pharmaceutical USD 22.56M 3.35M Mar/2026
Exelixis USD 16.13M 1.3M Mar/2026
Immunic USD -0.24 0.03 Sep/2024
Incyte USD 33.69M 2.93M Mar/2026
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
MacroGenics USD 1.53M 114K Sep/2025
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Prothena USD 3.35M 443K Sep/2025
Regeneron Pharmaceuticals USD 193.3M 18.2M Dec/2025
Ultragenyx Pharmaceutical USD 6.51M 649K Dec/2025
Vertex Pharmaceuticals USD 114.8M 7.1M Mar/2026